In this episode of the Ownership Economy, we speak with Molecule Protocol’s Co-Founder and Chief Scientific Officer Tyler Golato. Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. The company is connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset. We talk with Tyler about the model, how the company isapproaching progressive decentralization, and where algorithmic rules of governance intersect with the need for human decision making. We hope you enjoy the episode.

Show notes:

1. An Open Bazaar for Drug Development: Molecule Protocol | by Paul Kohlhaas
2. https://gov.vitadao.com/t/what-are-working-group-stewards/482
3. Robert Fine Columbia, cheapest possible cancer interventions
4. PsyDAO
5. Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
6. arXiv.org
7. Endurance : : Shackleton's incredible voyage /
8. VDP-54.1 Expression of Interest: Pfizer Ventures - Strategic Contributor Proposals - VitaDAO
9. Decentralized investor communities gain traction in biotech | Nature Biotechnology